When Barron’s recently recommended TJX Cos. stock, we ticked off multiple reasons: low valuation, strong value reputation, a growing dividend. Now, we have another:...
By Cecilia Butini AstraZeneca PLC reported first-quarter results on Thursday. Here is what we watched. REVENUE: Revenue declined to $10.88 billion from $11.39 billion...
By Herbert Lash and Alun John NEW YORK/LONDON (Reuters) -The dollar strengthened on Wednesday, lifted by rising Treasury yields, though the pound gained against...
By Jason Pratt Residential whole loans present insurance investors with a unique opportunity in terms of SCR charge and credit quality. With yields in...